Atlas Trials

A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity

Clinical trial NCT03842202 · COMPLETED

Trial details

NCT number
NCT03842202
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
OverweightObesity
Start date
2019-02-15
Primary completion
2019-11-04
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.